- Home
- SHEN vs NVCT Comparison
SHEN vs NVCT Comparison
Compare SHEN & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHEN | NVCT |
|---|---|---|
| Founded | 1902 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 635.1M | 608.8M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SHEN | NVCT |
|---|---|---|
| Price | $13.26 | $18.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $26.00 | $10.00 |
| AVG Volume (30 Days) | ★ 519.6K | 229.3K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $357,854,000.00 | N/A |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.08 | N/A |
| 52 Week Low | $9.67 | $5.55 |
| 52 Week High | $17.35 | $29.28 |
Technical Indicators
Market Signals| Indicator | SHEN | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 48.71 |
| Support Level | $10.94 | $18.02 |
| Resistance Level | $13.44 | $23.12 |
| Average True Range (ATR) | 0.68 | 1.52 |
| MACD | 0.31 | -0.37 |
| Stochastic Oscillator | 82.50 | 18.16 |
Price Performance
Historical ComparisonAbout SHEN Shenandoah Telecommunications Co
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.